Should You Hold Stevanato Group S.p.A. (STVN) for the Long-Term?

Investment management company Ave Maria recently released its “Ave Maria World Equity Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund returned 13.99% compared to the MSCI All Country World Index’s 11.03% return. The fund returned 24.96% for the full year compared to the 22.20% return for the index. You can check the top 5 holdings of the fund to know its best picks in 2023.

Ave Maria World Equity Fund featured stocks like Stevanato Group S.p.A. (NYSE:STVN) in the fourth quarter 2023 investor letter. Headquartered in Piombino Dese, Italy, Stevanato Group S.p.A. (NYSE:STVN) produces and distributes products and processes for biopharma and healthcare. On March 11, 2024, Stevanato Group S.p.A. (NYSE:STVN) stock closed at $28.55 per share. One-month return of Stevanato Group S.p.A. (NYSE:STVN) was -11.80%, and its shares gained 21.70% of their value over the last 52 weeks. Stevanato Group S.p.A. (NYSE:STVN) has a market capitalization of $7.579 billion.

Ave Maria World Equity Fund stated the following regarding Stevanato Group S.p.A. (NYSE:STVN) in its fourth quarter 2023 investor letter:

“Stevanato Group S.p.A. (NYSE:STVN) is a leading provider of drug containment products and serves many of the leading pharmaceutical and biotechnology companies. The company is a long-term beneficiary from the transition from small molecule drugs to biologics.”

A scientist in a laboratory observing a drug delivery system through a microscope.

Stevanato Group S.p.A. (NYSE:STVN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. At the end of the fourth quarter, Stevanato Group S.p.A. (NYSE:STVN) was held by 13 hedge fund portfolios, up from 11 in the previous quarter, according to our database.

We discussed Stevanato Group S.p.A. (NYSE:STVN) in another article and shared Conestoga Capital Advisors’ views on the company. In addition, please check out our hedge fund investor letters Q4 2023 page for more investor letters from hedge funds and other leading investors.

Suggested Articles:

• 15 Best Steakhouses in The US
• 10 Alternatives to Antidepressant Medications
• Alternatives to Silicone Breast Implants and 10 Cheap Countries for Augmentation

Disclosure: None. This article is originally published at Insider Monkey.